CDMOBiovian and 3P Biopharmaceuticals join for...Biovian and 3P Biopharmaceuticals have created a new pan-European CDMO, dubbed 3PBIOVIAN. more ➔
RNALonza and Oxford Nanopore collaborate to a...To improve mRNA product analysis, the Lonza Group Ltd. and Oxford Nanopore Technologies plc. are working together to develop and market a test to assess multiple critical quality attributes of mRNA … more ➔
CRO£26m for Cystic Fibrosis Drug Trial Enterprise Therapeutics Ltd. has raised £26m for the Phase IIa trial of ETD001, a novel cystic fibrosis treatment, with investment led by Panakes Partners and participation from existing investors. more ➔
BiosimilarsAlvotech Advances in Biosimilar Market wit...AVT03, a biosimilar candidate for osteoporosis treatment, showed promise in treating bone illnesses, according to results from a pharmacokinetic study by Alvotech SA. more ➔
M&ANovozymes and Chr. Hansen Complete Merger,...Danish Novozymes A/S and Chr. Hansen Holding A/S have completed their merger, creating a new company named Novonesis. more ➔
NGT2:1 for new genomic techniquesFollowing the AGRI Committee of the European Parliament, the lead ENVI Committee has also agreed to relax the rules for the authorisation of NGTs. more ➔
M&AInnate immunity merger raises €75mForbion has spearheaded a €75m Series A financing in Norwegian biotech Calluna Pharma. The clinical-stage company resulted from the merger of Oxitope Pharma and Arxx Therapeutics. more ➔
partnershipRoche jumps ship on AC ImmuneGenentech, Roches US subsidiary, is ending its decades-long collaboration with AC Immune SA after disappointing study results. It has handed the global rights to Crenezumab and Semorinemab back to … more ➔
NGTDeregulation of new genomic techniques bef...After the EU Parliament’s Agriculture (AGRI) Committee called for a patent ban on NGT-1 breeds on 8 January, the ENVI Committee will give its input to the EU Commissions draft law on new genomic tec … more ➔
bioeconomyAmsilk partners with 21st.BIOAMSilk GmbH and Danish 21st.BIO A/S announce partnership to accelerate the production of advanced materials made from spider silk-based proteins. more ➔
